Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on December 5, 2007
J Am Soc Nephrol 19: 269-280, 2008
© 2008 American Society of Nephrology
doi: 10.1681/ASN.2007010074

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2007010074v1
19/2/269    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, F.
Right arrow Articles by Chan, J. S.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, F.
Right arrow Articles by Chan, J. S.D.

BASIC RESEARCH

Overexpression of Angiotensinogen Increases Tubular Apoptosis in Diabetes

Fang Liu*, Marie-Luise Brezniceanu*, Chih-Chang Wei*, Isabelle Chénier*, Sébastien Sachetelli*, Shao-Ling Zhang*, Janos G. Filep{dagger}, Julie R. Ingelfinger{ddagger} and John S.D. Chan*

* Université de Montréal, Centre hospitalier de l’Université de Montréal (CHUM)-Hôtel-Dieu, Research Centre Pavillon Masson, Montreal, Quebec, Canada; {dagger} Université de Montréal, Maisonneuve-Rosemont Hospital, Research Centre, Montreal, Quebec, Canada; and {ddagger} Harvard Medical School, Massachusetts General Hospital, Pediatric Nephrology Unit, Boston, Massachusetts

Correspondence: John S. D. Chan, Université de Montréal Centre hospitalier de l’Université de Montréal (CHUM)-Hôtel-Dieu, Research Centre Pavillon Masson, 3850 Saint Urbain Street, Montreal, Quebec, Canada H2W 1T8. Phone: 514-890-8000 ext. 15080; Fax: 514-412-7204; E-mail: john.chan{at}umontreal.ca

Received for publication January 19, 2007. Accepted for publication August 17, 2007.

The intrarenal renin-angiotensin system (RAS) plays an important role in the progression of diabetic nephropathy. We have previously reported that mice overexpressing angiotensinogen in renal proximal tubular cells (RPTC) develop hypertension, albuminuria, and renal injury. Here, we investigated whether activation of the intrarenal RAS contributes to apoptosis of RPTC in diabetes. Induction of diabetes with streptozotocin in these transgenic mice led to significant increases in BP, albuminuria, RPTC apoptosis, and proapoptotic gene expression compared with diabetic nontransgenic littermates. Insulin and/or RAS blockers markedly attenuated these changes. Hydralazine prevented hypertension but not albuminuria, RPTC apoptosis, or proapoptotic gene expression. In vitro, high-glucose medium significantly increased apoptosis and caspase-3 activity in rat immortalized RPTC overexpressing angiotensinogen compared with control cells, and these changes were prevented by insulin and/or RAS blockers. In conclusion, intrarenal RAS activation and high glucose may act in concert to increase tubular apoptosis in diabetes, independent of systemic hypertension.







HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP